Today: 30 June 2026
Browse Category

NASDAQ:QLGN 24 October 2025

Qualigen (QLGN) Stock Rockets on Crypto Pivot – But Experts Warn It’s a Risky Bet

Qualigen (QLGN) Stock Rockets on Crypto Pivot – But Experts Warn It’s a Risky Bet

On Oct. 23, after the market close, Qualigen released a press statement announcing its BitGo partnershipglobenewswire.comstocktitan.net. In after-hours trading, that news sent QLGN skyrocketing: Benzinga reported a 62.6% jump after-hoursbenzinga.com. The frenzy continued into Oct. 24: TipRanks noted the stock was up more than 100% pre-market on Friday, reflecting a dramatic market reactiontipranks.com. By midday Friday the stock was trading in the $5–$6 range, roughly double its pre-news price. Qualigen’s deal with BitGo is highly unusual for a biotech: the company is effectively turning part of its cash treasury into a cryptocurrency investment fund. Under the terms announced, Qualigen will allocate about $30 million to buy a weighted basket of the top 10 coinsstocktitan.net. BitGo’s over-the-counter trading desk and cold storage infrastructure will manage these digital assets.
24 October 2025

Stock Market Today

  • Concentrix Q2 EPS Comes In Light, Stock Down Nearly 40% for the Year
    June 29, 2026, 7:00 PM EDT. Concentrix (CNXC) posted Q2 earnings of $2.63 a share, a penny below the Zacks Consensus of $2.64. Revenue was $2.46 billion, a 0.43% miss versus estimates, but up from $2.42 billion last year. Concentrix has only topped earnings estimates once in the past four quarters. Shares have dropped about 39.9% since the start of the year, trailing the S&P 500, which is up 7.4%. CNXC has a Zacks Rank #3 (Hold) as earnings estimate revisions remain uneven. Analysts are looking for $3.18 EPS and $2.54 billion revenue next quarter; full-year revenue is forecast at $11.65 billion. The Business-Services group sits in the top 42% of Zacks sectors. Investors are focused on the company's earnings call for any update on guidance.
Go toTop